Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000170389 | SCV000222809 | pathogenic | Cockayne syndrome type 2 | 2014-07-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001850426 | SCV002165605 | pathogenic | not provided | 2022-08-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1302*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 190170). This variant has not been reported in the literature in individuals affected with ERCC6-related conditions. This variant is present in population databases (rs786205174, gnomAD 0.0009%). |
Fulgent Genetics, |
RCV005042366 | SCV005680100 | pathogenic | DE SANCTIS-CACCHIONE SYNDROME; Cerebrooculofacioskeletal syndrome 1; Cockayne syndrome type 2; UV-sensitive syndrome 1; Age related macular degeneration 5; Premature ovarian failure 11; Lung cancer | 2024-05-11 | criteria provided, single submitter | clinical testing |